Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?

Abby Statler, PhD MPH, Brian P. Hobbs, PhD, Tomas Radivoyevitch, PhD, Sudipto Mukherjee, MD PhD MPH, Kimberly Bell, MBA, RN, BSN, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Aziz Nazha, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS

Blood (2019) 134 (Supplement_1): 381.

https://doi.org/10.1182/blood-2019-129096

Published: 2019

Journal Articles

A Phase II Non-Randomized Study to Evaluate the Efficacy of Single Dose Rasburicase (1.5mg) in Adult Acute Leukemia and High Grade Lymphomas with Established Tumor Lysis Syndrome

Jayshree Thorat, MD, Swaratika Majumdar, MDDM, Hasmukh Jain, MD DM, Avinash Bonda, MD DM, Lingaraj Nayak, MDDM MDcal Oncology, Bhausaheb Bagal, MD DM, Manju Sengar, MD DM

Blood (2019) 134 (Supplement_1): 2914.

https://doi.org/10.1182/blood-2019-128755

Published: 2019

Journal Articles

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

Abby Statler, PhDMPH, Brian P. Hobbs, PhD, Tomas Radivoyevitch, PhD, Caitlin Siebenaller, PharmD, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Aziz Nazha, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS

Blood (2019) 134 (Supplement_1): 3836.

https://doi.org/10.1182/blood-2019-128853

Published: 2019

Journal Articles

The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy

Blood (2019) 134 (Supplement_1): 16.

https://doi.org/10.1182/blood-2019-130319

Published: 2019

Journal Articles

Iron Chelation and Ferritin below 500 Mcg/L in Transfusion Dependent Thalassemia: Beyond the Limits of Clinical Trials

Natalia Scaramellini, MD, Carola Arighi, MD, Alessia Marcon, MD, Dario Consonni, MD, Elena Cassinerio, MD, Giovanna Graziadei, MD, Maria Domenica Cappellini, MD, Irene Motta, MD

Blood (2019) 134 (Supplement_1): 3542.

https://doi.org/10.1182/blood-2019-130237

Published: 2019

Journal Articles

Haemophilic Arthropathy Is a Risk Factor for Reduced Bone Mineral Density and Vitamin D Deficiency

M. Cem Ar, MD PhD, Serdar Sahin, MD, Sevil Sadri, MD, Isil Erdogan, MD, Ayse Salihoglu, MD, Tugrul Elverdi, MD, Fevzi Firat Yalniz, MD, Ahmet Emre Eskazan, MD, Seniz Ongoren, MD Associated Proffessor, Teoman Soysal, MD, Yildiz Aydin, MD, Zafer Baslar, MD

Blood (2015) 126 (23): 4685.

https://doi.org/10.1182/blood.V126.23.4685.4685

Published: 2015

Journal Articles

Angiotensin Blockage with Losartan Is Associated with Decreased Albuminuria and Stable Renal Function in Adults and Children with HbSS on Hydroxyurea

Marianne E. Yee, MD MSc, Peter A. Lane, MD, James R. Eckman, MD, Antonio Guasch, MD

Blood (2015) 126 (23): 2183.

https://doi.org/10.1182/blood.V126.23.2183.2183

Published: 2015

Journal Articles

A Rare Case of Congenital Atransferrinemia: International Collaboration for Genetic Diagnosis

Hanan Nazir, MD, Murtadha K. Al-Khabori, MD MSc, FRCPC, Naschla Kohistani, MD, Jacek Puchalka, PhD, Christoph Klein, MD PhD

Blood (2014) 124 (21): 4883.

https://doi.org/10.1182/blood.V124.21.4883.4883

Published: 2014

Journal Articles

Evaluation of Early Glomerulopathy and Tubulopathy in Patients with Transfusion Dependent Thalassemia

Zeynep Karakas, Prof, Agageldi Annayev, MD, Altan Yalciner, MD, Sevinc Emre, Prof

Blood (2014) 124 (21): 4904.

https://doi.org/10.1182/blood.V124.21.4904.4904

Published: 2014

Journal Articles

A Comparison of Efficacy Between Recombinant Activated Factor VII (ARYOSEVEN TM ) and NOVOSEVEN® in Patients with Hereditary FVIII Deficiency with Inhibitor

Mohammad Faranoush, Hassan Abolghassemi, Gh Toogeh, Mehran Karimi, Peyman Eshghi, M Managhchi, MD, Hamid Hoorfar, Dehdezi B Keikhaei, B Mehrvar, Babak Khoein, K Kaymar, R Heshmat, Mohammad Baghaeipour, NB Mirbehbahhani, R Fayazfar, Majid Naderi, Minoo Ahmadinejad, F Mahbodi, Behrooz Vaziri

Blood (2014) 124 (21): 4299.

https://doi.org/10.1182/blood.V124.21.4299.4299

Published: 2014

Journal Articles

Estimated Glomerular Filtration Rate Changes In Patients (Pts) With Chronic Myeloid Leukemia (CML) Treated With Tyrosine Kinase Inhibitors (TKI)

Musa Yilmaz, MD, Hagop M. Kantarjian, MD, Alfonso Quintas-Cardama, MD, Susan O'Brien, MD, Jan A. Burger, MD, PhD, Alessandra Ferrajoli, MD, Gautam Borthakur, MBBS, Farhad Ravandi, MD, Sherry Pierce, Elias Jabbour, MD, Jorge E. Cortes, MD

Blood (2013) 122 (21): 1488.

https://doi.org/10.1182/blood.V122.21.1488.1488

Published: 2013

Journal Articles

Imatinib (IM) Plus Thalidomide (Thali), A Effective Combination For The Treatment Of Chronic Myeloid Leukemia (CML) Philadelphia ChromosomePositive (Ph +) In IM-Resistant Disease. Report Of 14 New Cases From A Single Center In Mexico

Rafael Hurtado Monroy, MD, Pablo Vargas-Viveros, MD, Eduardo Cervera Ceballos, MD, Judith Cruz Velazquez, Silvia Carrillo Munos, RN

Blood (2013) 122 (21): 5172.

https://doi.org/10.1182/blood.V122.21.5172.5172

Published: 2013

Journal Articles

Plasma Cell Myeloma Causing Hyperammonemia Associated with High Inpatient Mortality

Anthony Pham, MD, John L. Reagan, MD, Jorge J Castillo, MD

Blood (2012) 120 (21): 5002.

https://doi.org/10.1182/blood.V120.21.5002.5002

Published: 2012

Journal Articles

Dose Optimization of Deferasirox in Chelation Naïve Children with Thalassemia Major

Surekha Tony, MD, Murtadha K. Al-Khabori, MD, FRCPC, Ashraf Abdullah Saad, MBBS, Shahina Daar, MD, PhD, Mathew Zachariah, MD, Yasser Wali, MD, FRCPCH, (UK)

Blood (2011) 118 (21): 5294.

https://doi.org/10.1182/blood.V118.21.5294.5294

Published: 2011

Journal Articles

3G8 and GMA161, Anti FcγRIII Inhibitory Monoclonal Antibodies in the Treatment of Chronic Refractory ITP. (Summary of 2 Pilot Studies).

Charles T Nakar, MD, James B. Bussel, MD

Blood (2009) 114 (22): 2404.

https://doi.org/10.1182/blood.V114.22.2404.2404

Published: 2009

Journal Articles

Severe Rhabdomyolysis and Acute Renal Failure Secondary to Use of All–Trans-Retinoic Acid in a Patient with Acute Promyelocytic Leukemia.

Shenxian Qian, MD, Yaping Xie, Xilian Huang, DaQuan Gao, LiRong Liu, Kuang Chen

Blood (2009) 114 (22): 4138.

https://doi.org/10.1182/blood.V114.22.4138.4138

Published: 2009

Journal Articles

Safety and Efficacy of High Dose Intravenous Desferoxamine for Reduction of Iron Overload Due to Chronic Transfusion in Sickle Cell Patients.

Ram Kalpatthi, MD, Brittany Peters, David Holloman, Elizabeth Rackoffe, Deborah Disco, Sherron Jackson, Miguel Abboud, MD

Blood (2008) 112 (11): 1430.

https://doi.org/10.1182/blood.V112.11.1430.1430

Published: 2008

Journal Articles

Pregnancy Associated Thrombotic Thrombocytopenic Purpura: A Case Report.

Xu Ye, Ying Feng, Ying Pang, Zhaoyue Wang

Blood (2007) 110 (11): 3221.

https://doi.org/10.1182/blood.V110.11.3221.3221

Published: 2007

Journal Articles

Anti-D Immunglobulin in the Treatment of Childhood Chronic Idiopathic Thrombocytopenic Purpura.

Emine Turkkan, MD, Fugen Pekun, MD

Blood (2006) 108 (11): 3967.

https://doi.org/10.1182/blood.V108.11.3967.3967

Published: 2006

Journal Articles

Anti-Xa Levels and Renal Function: Analysis of the First 32 Patients in the Tinzaparin in Renal Insufficiency for Venous Thromboembolism Study.

Wendy Lim, MD, James Douketis, MD, Luqi Wang, PhD, Karen Woods, Terri Schnurr, Krystyna Kinnon, Rebecca Cruickshank, Catherine M. Clase, MD, Christian Rabbat, MD, Mark A. Crowther, MD

Blood (2005) 106 (11): 906.

https://doi.org/10.1182/blood.V106.11.906.906

Published: 2005

NARROW

Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?

A Phase II Non-Randomized Study to Evaluate the Efficacy of Single Dose Rasburicase (1.5mg) in Adult Acute Leukemia and High Grade Lymphomas with Established Tumor Lysis Syndrome

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy

Iron Chelation and Ferritin below 500 Mcg/L in Transfusion Dependent Thalassemia: Beyond the Limits of Clinical Trials

Haemophilic Arthropathy Is a Risk Factor for Reduced Bone Mineral Density and Vitamin D Deficiency

Angiotensin Blockage with Losartan Is Associated with Decreased Albuminuria and Stable Renal Function in Adults and Children with HbSS on Hydroxyurea

A Rare Case of Congenital Atransferrinemia: International Collaboration for Genetic Diagnosis

Evaluation of Early Glomerulopathy and Tubulopathy in Patients with Transfusion Dependent Thalassemia

A Comparison of Efficacy Between Recombinant Activated Factor VII (ARYOSEVEN TM ) and NOVOSEVEN® in Patients with Hereditary FVIII Deficiency with Inhibitor

Estimated Glomerular Filtration Rate Changes In Patients (Pts) With Chronic Myeloid Leukemia (CML) Treated With Tyrosine Kinase Inhibitors (TKI)

Imatinib (IM) Plus Thalidomide (Thali), A Effective Combination For The Treatment Of Chronic Myeloid Leukemia (CML) Philadelphia ChromosomePositive (Ph +) In IM-Resistant Disease. Report Of 14 New Cases From A Single Center In Mexico

Plasma Cell Myeloma Causing Hyperammonemia Associated with High Inpatient Mortality

Dose Optimization of Deferasirox in Chelation Naïve Children with Thalassemia Major

3G8 and GMA161, Anti FcγRIII Inhibitory Monoclonal Antibodies in the Treatment of Chronic Refractory ITP. (Summary of 2 Pilot Studies).

Severe Rhabdomyolysis and Acute Renal Failure Secondary to Use of All–Trans-Retinoic Acid in a Patient with Acute Promyelocytic Leukemia.

Safety and Efficacy of High Dose Intravenous Desferoxamine for Reduction of Iron Overload Due to Chronic Transfusion in Sickle Cell Patients.

Pregnancy Associated Thrombotic Thrombocytopenic Purpura: A Case Report.

Anti-D Immunglobulin in the Treatment of Childhood Chronic Idiopathic Thrombocytopenic Purpura.

Anti-Xa Levels and Renal Function: Analysis of the First 32 Patients in the Tinzaparin in Renal Insufficiency for Venous Thromboembolism Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only